Ardelyx sued for securities law violations

Ardelyx, Inc. is facing a class action lawsuit for alleged violations of U.S. securities laws, filed by the DJS Law Group. The lawsuit claims the company made misleading statements to the market regarding delays in new patient starts and prescription fulfillment for its products XPHOZAH and IBSRELA. The class period for shareholders is from January 13, 2025, to August 6, 2026, with a deadline to contact the firm by November 16, 2026.